These findings align with previous literature reports, which state that approximately 50% to 57% of patients with NKX2-1 gene abnormalities may display the complete triad of the syndrome, and both hypothyroidism and central nervous system abnormalities are observed in 30% of patients [52, 60]. Here, NKX2-1 is linked to hypothyroidism.